Table 1. List of investigations.
MCV: Mean corpuscular volume; WBC: White blood cells; ESR: Erythrocyte sedimentation rate; BUN: Blood urea nitrogen; CRP: C-reactive protein; TSH: Thyroid-stimulating hormone; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; VLDL: Very low-density lipoprotein; Gamma GT: Gamma-glutamyl transferase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; PT: Prothrombin time; INR: International normalized ratio; WBC/HPF: White blood cells per high-powered field; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; LKM: Liver kidney microsome; ANA: Antinuclear antibody; HLA: Human leukocyte antigen; AMA: Antimitochondrial antibody.
| Hb 10.7 mg/dl | CRP 1.34 |
| MCV 74.5 fL | Albumin 4.4 g/dl |
| WBC 7.7 x 109/L | PT 10.1 |
| Platelets 249 x 109/L | INR 0.9 |
| ESR 25 mm/hour | Glucose random 99 mg/dl |
| Serum iron 34.0 microgram/dl | Serum 25-hydroxy vitamin D 19.5 ng/ml |
| Total iron-binding capacity (TIBC) 379 micrograms/dl | Serum calcium 8.9 mg/dl |
| Transferrin saturation 8.97% | Serum B12 192 pg/ml |
| Serum ferritin 7.1 ng/ml | Stool analysis. occasional WBC/HPF |
| Glycosylated hemoglobin (HbA1c) 6.1% | H. pylori stool antigen Negative |
| TSH 0.097 uIU/ml | Serum cortisol 14.80 ug/dl |
| BUN 11 mg/dl | Serum anti-transglutaminase IgA >100 U/ml |
| Serum cholesterol 98 mg/dl | Serum anti-transglutaminase IgG <0.5 |
| Serum triglycerides 110 mg/dl | HBsAg Non-reactive |
| HDL cholesterol 54 mg/dl | HCV antibody non-reactive |
| LDL cholesterol 54 mg/dl | Serum LKM IgG 1.14 U/ML |
| VLDL cholesterol 22 mg/dl | Serum ceruloplasmin 0.28 G/L |
| Total bilirubin 0.5 mg/dl | Anti-DsDNA 2.01 IU/ml |
| Direct bilirubin 0.2 mg/dl | AMA negative |
| Indirect bilirubin 0.3 mg/dl | ANA negative |
| Gamma GT 45 IU/L | HLA DQ2 Negative |
| ALT 70 IU/L | HLA DQ8 Negative |
| Alk Phosphatase 79 IU/L | |
| AST 64 IU/L | |
| Serum Na 137 mmol/L | |
| Serum potassium 4.1 mmol/L |